Professor of Surgery and Chair, Emeritus, Division of Vascular and Endovascular Surgery
Mayo Clinic
Mayo Clinic
Scottsdale, AZ, United States
Peter Gloviczki, MD, PhD, FACS, DFSVS, DFAVF, Roberts Emeritus Professor of Surgery, previous Chair, Division of Vascular and Endovascular Surgery, at Mayo Clinic, Rochester, MN, previous Editor-in-Chief, JVS, JVS-Venous and Lymphatic Disorders . Received MD at Semmelweis University, trained in Budapest, Paris, at Mayo Clinic. Joined the Mayo Clinic staff in 1987. His clinical practice included arterial, venous, lymphatic surgery. Expert in venous reconstructions, vascular malformations, lymphatic and chylous disorders. At Mayo Clinic, he performed over 10,000 operations. Past President of Frank J. Veith International Society, Society for Vascular Surgery , American Venous Forum, International Union of Angiology, World Federation of Vascular Societies, Society for Clinical Vascular Surgery, among others. Member of ASA, Honorary Member of 19 societies, including AVLS. Has 506 peer-reviewed publications, wrote >250 book-chapters, edited eight textbooks, four Editions of Handbook of Venous and Lymphatic Disorders, translated to Chinese and Polish. Gave >700 presentations, has 27,873 citations on SCOPUS, an h-index of 91. The University of Washington, Seattle, established the Peter Gloviczki Professorship in Venous and Lymphatic Disorders. His Alma Mater awarded him the “Doctor Honoris Causa” degree and the “Semmelweis Budapest” Award. He serves on the Board of Trustees of Semmelweis University. Dr Gloviczki received the Officer’s Cross of the Order of Merit of the Republic of Hungary. In 2023, Dr Gloviczki also received Honorary Doctorate Degree from Padua University, Italy. His biography “Magic and Medicine” was recently published by Semmelweis University. Dr Gloviczki lives with his wife, Monika Gloviczki, MD, PhD, in Scottsdale, Arizona.
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose.
SVS, AVF and AVLS Multisocietal Guideline
Sunday, September 17, 2023
8:46 AM – 9:00 AM US EDT
Optimum outcome measures for venous thrombectomy trials: a Delphi consensus.
Sunday, September 17, 2023
11:01 AM – 11:15 AM US EDT
Epidemiology of Superficial Venous Disease in North America
Sunday, September 17, 2023
2:20 PM – 2:29 PM US EDT
Against: Perforator Surgery May Be There Is a Need After All?
Monday, September 18, 2023
5:01 PM – 5:20 PM US EDT
Chronic Deep Venous Obstruction
Wednesday, September 20, 2023
7:43 AM – 7:54 AM US EDT
Thursday, September 21, 2023
9:23 AM – 9:33 AM US EDT